scispace - formally typeset
N

Nathalie Rioux-Leclercq

Researcher at University of Rennes

Publications -  302
Citations -  11153

Nathalie Rioux-Leclercq is an academic researcher from University of Rennes. The author has contributed to research in topics: Renal cell carcinoma & Clear cell renal cell carcinoma. The author has an hindex of 46, co-authored 280 publications receiving 9481 citations. Previous affiliations of Nathalie Rioux-Leclercq include Centre national de la recherche scientifique & Radboud University Nijmegen.

Papers
More filters
Journal ArticleDOI

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

TL;DR: RCC appears to be more common in patients with obesity, end-stage renal failure, acquired renal cystic disease and tuber-ous sclerosis, and severalautosomal dominant syndromes are described, each with a dis-tinct genetic basis and phenotype.
Journal ArticleDOI

The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

John R. Srigley, +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.
Journal ArticleDOI

The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

Brett Delahunt, +131 more
TL;DR: The International Society of Urological Pathology 2012 Consensus Conference made recommendations regarding classification, prognostic factors, staging, and immunohistochemical and molecular assessment of adult renal tumors.
Journal ArticleDOI

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

TL;DR: The stratification in three main renal cell carcinoma histologic subtypes as defined by the 1997 UICC-American Joint Committee on Cancer consensus should not be considered a major prognostic variable comparable to TNM stage, Fuhrman grade and ECOG PS.